TABLE 3.

Serogroup C-specific IgG GMCs and 95% CIs before and 1, 2, 12, and 24 months following administration of Menitorix at 12 to 14 months of age, by priming MCC vaccine

Time from administration of Menitorix (mo)ParameterResult obtained with the following priming meningococcal serogroup C conjugate vaccine:
All combinedMeningitecMenjugateNeisVac-C
PreboostingNo. of subjects206706665
GMC (95% CI)0.54 (0.48-0.62)0.52 (0.42-0.64)0.59 (0.47-0.73)0.53 (0.42-0.68)
1No. of subjects250809176
GMC (95% CI)7.11 (6.35-7.95)6.73 (5.47-8.28)5.98 (5.04-7.09)9.39 (7.63-11.55)
2No. of subjects124364443
GMC (95% CI)5.64 (4.78-6.66)5.00 (3.67-6.81)4.53 (3.44-5.96)8.02 (6.09-10.57)
12No. of subjects217638366
GMC (95% CI)0.73 (0.63-0.84)0.65 (0.53-0.8)0.67 (0.52-0.86)0.90 (0.69-1.17)
24No. of subjects125354542
GMC (95% CI)0.41 (0.34-0.48)0.43 (0.32-0.59)0.39 (0.30-0.51)0.41 (0.30-0.56)